Tuesday morning snapshot

A snapshot of the early morning's equity news and key market movements.

Last night in the US: The Dow Jones closed up 40  points at 16,449, the NASDAQ finished up 25 points at 3559 and the S&P 500 ended the day up seven points at 1871.

This morning in London: The FTSE 100 is currently up 58 points at 6683.

FX and commodities: GBP/USD is up 22 pips at $1.6813, EUR/USD is up ten pips at $1.3803 and USD/JPY is down ten pips at ¥102.51. Brent crude is down eight cents at $109.91 and gold is trading at $1289, down $1.

Stocks: GlaxoSmithKline will return £4 billion to its shareholders after it struck a deal with Swiss drug maker Novartis to exchange assets. Pharmaceutical company AstraZeneca is believed to be in takeover talks with Pfizer.

The day ahead: In the US, the house price index is due out at 2pm, followed by existing home sales and the Richmond manufacturing index at 3pm.

All figures correct at 8.15am. All times London time.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.